Patient Access Network Foundation Opens New Acute Myeloid Leukemia Patient Assistance Fund
For Immediate Release
PAN Foundation Contact:
Margaret Figley, Director of Communications
Washington, DC, (June 16, 2017) - The Patient Access Network (PAN) Foundation today opened a new patient assistance program for Medicare patients with acute myeloid leukemia (AML). Qualifying patients are eligible to receive grants for their out-of-pocket costs associated with their prescribed AML medications.
“The PAN Foundation is pleased to support people living with acute myeloid leukemia,” said PAN President and CEO Daniel Klein. “When people—and their families—receive a diagnosis like AML, the financial implications can be tremendous. We are committed to finding ways to ease those financial burdens, so that people living with acute myeloid leukemia can focus on feeling better, getting through their treatments and hopefully recovering.”
Patients who qualify for the PAN Foundation’s AML program are eligible to receive up to $5,500 per year in financial assistance. Eligible patients must be getting treatment for AML; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.
Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.
About the PAN Foundation:
The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.